Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine

Placental malaria is a public health burden particularly in Africa as it causes severe symptoms and results in stillbirths or maternal deaths. Plasmodium falciparum protein VAR2CSA drives placental malaria (PM) in pregnant women by adhering to chondroitin sulfate A (CSA) on the placenta. VAR2CSA is...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jasmita Gill, Soumyananda Chakraborti, Praveen Bharti, Amit Sharma
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/4d93b7dffb8048b6804bbe02d5ef6b4c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4d93b7dffb8048b6804bbe02d5ef6b4c
record_format dspace
spelling oai:doaj.org-article:4d93b7dffb8048b6804bbe02d5ef6b4c2021-11-30T04:14:01ZStructural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine1201-971210.1016/j.ijid.2021.08.054https://doaj.org/article/4d93b7dffb8048b6804bbe02d5ef6b4c2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1201971221006871https://doaj.org/toc/1201-9712Placental malaria is a public health burden particularly in Africa as it causes severe symptoms and results in stillbirths or maternal deaths. Plasmodium falciparum protein VAR2CSA drives placental malaria (PM) in pregnant women by adhering to chondroitin sulfate A (CSA) on the placenta. VAR2CSA is a primary vaccine candidate for PM with two vaccines based on it already under clinical trials. The first cryo-EM three-dimensional structure of Pf CSA-VAR2CSA complex revealed crucial interacting residues considered to be highly conserved across P. falciparum strains. In the current study, we have conducted a global sequence analysis of 1,114 VAR2CSA field isolate sequences from more than nine countries across three continents revealing numerous mutations in CSA-binding residues. Further, structural mapping has revealed significant polymorphisms on the ligand binding surfaces. The variants from this limited set of 1,114 sequences highlight the concerns that are vital in current considerations for development of vaccines based on VAR2CSA for placental malaria.Jasmita GillSoumyananda ChakrabortiPraveen BhartiAmit SharmaElsevierarticlePlacental malariaVAR2CSAPlacental malaria vaccineField isolates, Structural mappingInfectious and parasitic diseasesRC109-216ENInternational Journal of Infectious Diseases, Vol 112, Iss , Pp 35-39 (2021)
institution DOAJ
collection DOAJ
language EN
topic Placental malaria
VAR2CSA
Placental malaria vaccine
Field isolates, Structural mapping
Infectious and parasitic diseases
RC109-216
spellingShingle Placental malaria
VAR2CSA
Placental malaria vaccine
Field isolates, Structural mapping
Infectious and parasitic diseases
RC109-216
Jasmita Gill
Soumyananda Chakraborti
Praveen Bharti
Amit Sharma
Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine
description Placental malaria is a public health burden particularly in Africa as it causes severe symptoms and results in stillbirths or maternal deaths. Plasmodium falciparum protein VAR2CSA drives placental malaria (PM) in pregnant women by adhering to chondroitin sulfate A (CSA) on the placenta. VAR2CSA is a primary vaccine candidate for PM with two vaccines based on it already under clinical trials. The first cryo-EM three-dimensional structure of Pf CSA-VAR2CSA complex revealed crucial interacting residues considered to be highly conserved across P. falciparum strains. In the current study, we have conducted a global sequence analysis of 1,114 VAR2CSA field isolate sequences from more than nine countries across three continents revealing numerous mutations in CSA-binding residues. Further, structural mapping has revealed significant polymorphisms on the ligand binding surfaces. The variants from this limited set of 1,114 sequences highlight the concerns that are vital in current considerations for development of vaccines based on VAR2CSA for placental malaria.
format article
author Jasmita Gill
Soumyananda Chakraborti
Praveen Bharti
Amit Sharma
author_facet Jasmita Gill
Soumyananda Chakraborti
Praveen Bharti
Amit Sharma
author_sort Jasmita Gill
title Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine
title_short Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine
title_full Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine
title_fullStr Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine
title_full_unstemmed Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine
title_sort structural insights into global mutations in the ligand-binding domain of var2csa and its implications on placental malaria vaccine
publisher Elsevier
publishDate 2021
url https://doaj.org/article/4d93b7dffb8048b6804bbe02d5ef6b4c
work_keys_str_mv AT jasmitagill structuralinsightsintoglobalmutationsintheligandbindingdomainofvar2csaanditsimplicationsonplacentalmalariavaccine
AT soumyanandachakraborti structuralinsightsintoglobalmutationsintheligandbindingdomainofvar2csaanditsimplicationsonplacentalmalariavaccine
AT praveenbharti structuralinsightsintoglobalmutationsintheligandbindingdomainofvar2csaanditsimplicationsonplacentalmalariavaccine
AT amitsharma structuralinsightsintoglobalmutationsintheligandbindingdomainofvar2csaanditsimplicationsonplacentalmalariavaccine
_version_ 1718406800356671488